Natriuretic Peptide Receptor as a Biomarker for Cancer

Our inventors have come up with a diagnostic method for differentiating low grade cancers from high grade cancers by correlating the level of NPRA to favorable or unfavorable prognosis. With this method, clinical detection of a number of malignancies, amongst included are various cancers, can be diagnosed and treated earlier improving the chances for those affected to lead normal, healthy lives.  

•     Multiple cancer and tumor type prognostic screening
•     Can use patients’ own cells as a control
•     Early indication of a variety of malignant disease
•     Detection of malignancy in a subject

Mean NPRA Scores for Various Stages of Prostate Cancer